{"organizations": ["Battery Bank", "Morgan Stanley Global Healthcare Conference", "Gilead", "Association", "AMA House of Delegates IPC The Hospitalist Company, Inc", "NYSM", "Pfizer Settle Lipitor Litigation Worldwide Monogram Biosciences Collaborates", "Ranbaxy", "Neurocrine Biosciences", "The American Medical", "Neurocrine", "EGen Battery Bank", "Gilead Sciences", "Hospitalist Company, Inc.", "Neurocrine ... Healthcare Conference", "Global Dementia Partnering", "NewsWatch"], "uuid": "e57799f5d5e341bd421e9af14afd3cd8d4eb9d30", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Pneumonia-Vaccine-Market-Outlook-2020-48243-1/", "country": "US", "title": "Global Pneumonia Vaccine Market Outlook 2020", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Global Pneumonia Vaccine Market Outlook 2020", "spam_score": 0.0, "site_type": "news", "published": "2015-09-10T15:19:00.000+03:00", "replies_count": 0, "uuid": "e57799f5d5e341bd421e9af14afd3cd8d4eb9d30"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Pneumonia-Vaccine-Market-Outlook-2020-48243-1/", "ord_in_thread": 0, "title": "Global Pneumonia Vaccine Market Outlook 2020", "locations": ["US", "Europe", "Boston", "CORVALLIS", "New York City", "Ore", "Calif.", "New York", "U.S.", "Arizona", "Poulsbo", "SAN DIEGO", "GURGAON"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Gurman", "Mark Webinar", "Andrew W. Gurman", "Mark", "Kevin Gorman", "Amanda Forstrom", "EGen"], "text": "  The Dementia ... the dementia partnering deals and agreements entered into ... in dementia partnering deals Top dementia deals by ... stage of development, technology type The Dementia ... dementia partnering deals and agreements entered into by ... (Date:9/10/2015)... SAN DIEGO , Sept. 10, 2015 Neurocrine ... Kevin Gorman , resident and CEO of Neurocrine ... Healthcare Conference in New York City ... Thursday, September 17 at 8:00am ET (5:00am PT). The ... the Company,s website at http://www.neurocrine.com . ... (Date:9/10/2015)... Sept. 10, 2015 Orthology, an innovative, cost-effective ... injuries, chronic pain, and orthopedic surgeries, as well ... (NYSM), New York,s leading ... company. NYSM currently operates three NYC locations at ... Based on a patent-pending, research-based methodology developed ... [ 0 ] Global Dementia Partnering 2010-2015 [ 0 ] Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference [ 0 ] Orthology Acquires NYSportsMed In New York City  9/10/2015)... Arizona (PRWEB) , ... September ... ... the upcoming book titled Outliers in Medicine with exclusive interviews from six ... offer medical career advice and detail their professional growth experiences and accomplishments. ... (Date:9/10/2015)... ... September 10, 2015 , ... The numbers show economic growth is strong in and around ... best yet. Or rather, a coveted pair of letters… , At a time when Standard ... the few cities of its size granted that strong vote of confidence. , “For   conceptualized as ...   selected licensing ... program   business essentials ... (Date:9/10/2015)... Church, VA (PRWEB) , ... September 10, 2015 ... ... Let Your Devices Lose Their CE Mark, **FDAnews Webinar**, Sept. 25, 2015 — ... certified to produce medical devices for sale in Europe is only the first ... (Date:9/10/2015)... ... ... The EGen Battery Bank was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... , Every homeowner or renter has to have electricity. There's just no way getting ... [ 0 ] Outliers Publishing Announces New Book, Outliers in Medicine [ 0 ] Poulsbo Receives a Gold Star for Its Financial Health   FDAnews Announces — Inspections Summit Preview: Recertification Audits — Don’t Let Your Devices Lose Their CE Mark Webinar, Sept. 25, 2015 [ 0 ] Cut a Home’s Electricity Bill with EGen’s Battery Bank ... CORVALLIS, Ore. Some migratory songbirds figure out the ... of others that successfully have had baby birds ... playing recorded songs induced them to nest in places ... songbirds have more complex communication abilities than had previously ... ... Will Market Generic Atorvastatin in the U.S. With 180 Days ... ... Also Resolves Caduet, Accupril Litigation in the US, GURGAON, ... (Ranbaxy), announced today that it has entered,into an agreement with ... ... and PhenoSense Integrase(TM) assays used to study ... promising new Integrase inhibitor, ... MGRM ) announced today that the Company has,signed an ... services for Gilead,s Elvitegravir Phase III,studies. Monogram assays will be ... ... June 18 Cytopia Limited (ASX:,CYT) will present details ... Protein Kinase Targets conference, a leading conference for,breakthrough scientific ... held from 23 to 25 June in Boston, USA., ... from the Cytopia FMS,program and will be presented by ... ... 17 The American Medical,Association (AMA) announced today ... orthopaedic hand surgeon, to his second consecutive,term as ... In this position, Dr.,Gurman will assist in presiding ... organization., \"I look forward to continuing to ... ... Calif., June 17 IPC The,Hospitalist Company, Inc. (Nasdaq: ... today announced that it continues to experience,favorable trends in ... be in the range of $57 million to $59 ... $4.2 million to $4.6 million. Absent the,impact of acquisitions, ... Birds communicate reproductive success in song Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies Cytopia To Present Data on FMS Program With Anticancer Potential Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook CRP Liquid Conrtols level 3... The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid.... Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma.... For the quantitative in vitro determination of Ammonia in plasma...", "external_links": [], "published": "2015-09-10T15:19:00.000+03:00", "crawled": "2015-09-11T13:24:16.326+03:00", "highlightTitle": ""}